Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Kwang Dae Hong"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer
Wonkyung Jung, Kwang Dae Hong, Woon Yong Jung, Eunjung Lee, Bong Kyung Shin, Han Kyeom Kim, Aeree Kim, Baek-hui Kim
Korean J Pathol. 2013;47(4):332-339.   Published online August 26, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.4.332
  • 9,595 View
  • 68 Download
  • 38 Crossref
AbstractAbstract PDF
Background

Silent mating type information regulation 2 homolog 1 (SIRT1), an NAD+-dependent deacetylase, might act as a tumor promoter by inhibiting p53, but may also as a tumor suppressor by inhibiting several oncogenes such as β-catenin and survivin. Deleted in breast cancer 1 (DBC1) is known as a negative regulator of SIRT1.

Methods

Immunohistochemical expressions of SIRT1, DBC1, β-catenin, surviving, and p53 were evaluated using 2 mm tumor cores from 349 colorectal cancer patients for tissue microarray.

Results

Overexpression of SIRT1, DBC1, survivin, and p53 was seen in 235 (67%), 183 (52%), 193 (55%), and 190 (54%) patients, respectively. Altered expression of β-catenin was identified in 246 (70%) patients. On univariate analysis, overexpression of SIRT1 (p=0.029) and altered expression of β-catenin (p=0.008) were significantly associated with longer overall survival. Expression of SIRT1 was significantly related to DBC1 (p=0.001), β-catenin (p=0.001), and survivin (p=0.002), but not with p53. On multivariate analysis, age, tumor stage, differentiation, and expression of SIRT1 were independent prognostic factors significantly associated with overall survival.

Conclusions

SIRT1 overexpression is a good prognostic factor for colorectal cancer, and SIRT1 may interact with β-catenin and survivin rather than p53.

Citations

Citations to this article as recorded by  
  • ZMIZ1 Regulates Proliferation, Autophagy and Apoptosis of Colon Cancer Cells by Mediating Ubiquitin–Proteasome Degradation of SIRT1
    Min Huang, Junfeng Wang, Zhengrong Zhang, Xueliang Zuo
    Biochemical Genetics.2024;[Epub]     CrossRef
  • Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
    Dong Hoon Shin, Jeong Yeon Jo, Minyoung Choi, Kyung-Hee Kim, Young-Ki Bae, Sang Soo Kim
    Experimental & Molecular Medicine.2023; 55(10): 2220.     CrossRef
  • Association of β-Catenin, APC, SMAD3/4, Tp53, and Cyclin D1 Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Hongfeng Yan, Fuquan Jiang, Jianwu Yang, Ying-Kun Xu
    Genetics Research.2022; 2022: 1.     CrossRef
  • Resveratrol-related compounds: Potential for cancer and beyond
    MONICA SAVIO, VALENTINA MINOIA, PAOLA FULGHIERI, LUCIA ANNA STIVALA, VIRGINIE SOTTILE
    BIOCELL.2022; 46(12): 2525.     CrossRef
  • The relationship between β-catenin and patient survival in colorectal cancer systematic review and meta-analysis
    Amna Matly, Jean A. Quinn, Donald C. McMillan, James H. Park, Joanne Edwards
    Critical Reviews in Oncology/Hematology.2021; 163: 103337.     CrossRef
  • Trending topics of SIRT1 in tumorigenicity
    Liz M. Garcia-Peterson, Xiaoling Li
    Biochimica et Biophysica Acta (BBA) - General Subjects.2021; 1865(9): 129952.     CrossRef
  • Surtuin 1 as a potential prognostic biomarker in very elderly patients with colorectal cancer
    Guk Jin Lee, Yun Hwa Jung, Tae-Jung Kim, Yosep Chong, Seo-Won Jeong, In Kyu Lee, In Sook Woo
    The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S235.     CrossRef
  • Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis
    Min Sun, Mengyu Du, Wenhua Zhang, Sisi Xiong, Xingrui Gong, Peijie Lei, Jin Zha, Hongrui Zhu, Heng Li, Dong Huang, Xinsheng Gu
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • SIRT1: a potential tumour biomarker and therapeutic target
    Bin Zhao, Xin Li, Liangfu Zhou, Ye Wang, Peng Shang
    Journal of Drug Targeting.2019; 27(10): 1046.     CrossRef
  • The clinicopathological significance of SIRT1 expression in colon cancer: An immunohistochemical study and meta-analysis
    Won Gi Hong, Jung-Soo Pyo
    Pathology - Research and Practice.2018; 214(10): 1550.     CrossRef
  • Sirtuin 1 and oral cancer (Review)
    Shajedul Islam, Yoshihiro Abiko, Osamu Uehara, Itsuo Chiba
    Oncology Letters.2018;[Epub]     CrossRef
  • A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53
    Ananga Ghosh, Amrita Sengupta, Guru Pavan Kumar Seerapu, Ali Nakhi, E.V. Venkat Shivaji Ramarao, Navneet Bung, Gopalakrishnan Bulusu, Manojit Pal, Devyani Haldar
    Biochemical and Biophysical Research Communications.2017; 488(3): 562.     CrossRef
  • SIRT1 gene polymorphisms and its protein level in colorectal cancer
    Olfat Gamil Shaker, Miriam Safwat Wadie, Reham Maher Mohamed Ali, Ayman Yosry
    Gene Reports.2017; 7: 164.     CrossRef
  • Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma
    David H. Mvunta, Tsutomu Miyamoto, Ryoichi Asaka, Yasushi Yamada, Hirofumi Ando, Shotaro Higuchi, Koichi Ida, Hiroyasu Kashima, Tanri Shiozawa
    Applied Immunohistochemistry & Molecular Morphology.2017; 25(6): 415.     CrossRef
  • SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p
    Li-Na Sun, Zheng Zhi, Liang-Yan Chen, Qun Zhou, Xiu-Ming Li, Wen-Juan Gan, Shu Chen, Meng Yang, Yao Liu, Tong Shen, Yong Xu, Jian-Ming Li
    Cancer Letters.2017; 409: 104.     CrossRef
  • TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer
    Zhen Chen, Chunlei Tang, Yaodan Zhu, Mingxu Xie, Dongxu He, Qiongxi Pan, Peng Zhang, Dong Hua, Teng Wang, Linfang Jin, Xiaowei Qi, Yifei Zhu, Xiaoqiang Yao, Jian Jin, Xin Ma
    Clinical Science.2017; 131(3): 227.     CrossRef
  • Meta-analysis of SIRT1 expression as a prognostic marker for overall survival in gastrointestinal cancer
    Shuangjie Wu, Jinghui Jiang, Jun Liu, Xinhai Wang, Yu Gan, Yifan Tang
    Oncotarget.2017; 8(37): 62589.     CrossRef
  • Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis
    Yifei Chen, Tao Wang, Wei Wang, Jiahao Hu, Ruiting Li, Shaojun He, Jiong Yang
    Oncotarget.2017; 8(37): 62537.     CrossRef
  • The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
    Changwen Wang, Wen Yang, Fang Dong, Yawen Guo, Jie Tan, Shengnan Ruan, Tao Huang
    Oncotarget.2017; 8(39): 66343.     CrossRef
  • SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer
    Min-Sun Jin, Chang Lim Hyun, In Ae Park, Ji Young Kim, Yul Ri Chung, Seock-Ah Im, Kyung-Hun Lee, Hyeong-Gon Moon, Han Suk Ryu
    Tumor Biology.2016; 37(4): 4743.     CrossRef
  • Survivin and SIRT1: can be two prognostic factors in chronic myeloid leukemia?
    Fatemeh Salari, Javad Mohammdai-asl, Amal Saki Malehi, Ahmad Ahmadzadeh, Mohammad Ali Jalali far, Zari Tahannejad Asadi, Najmaldin Saki
    Comparative Clinical Pathology.2016; 25(2): 415.     CrossRef
  • Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis
    Guo Zu, Anlong Ji, Tingting Zhou, Ningwei Che
    International Journal of Surgery.2016; 26: 32.     CrossRef
  • The small molecule survivin inhibitor YM155 may be an effective treatment modality for colon cancer through increasing apoptosis
    Wan Lu Li, Mi-Ra Lee, Mee-Yon Cho
    Biochemical and Biophysical Research Communications.2016; 471(2): 309.     CrossRef
  • Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma
    Shizhen Zhang, Zhen Wang, Jinlan Shan, Xiuyan Yu, Ling Li, Rui Lei, Daozhe Lin, Siqi Guan, Xiaochen Wang
    Medicine.2016; 95(49): e5546.     CrossRef
  • Association of SIRT1 and HMGA1 expression in non-small cell lung cancer
    SHUANG-YAN LIN, FANG PENG
    Oncology Letters.2016; 11(1): 782.     CrossRef
  • SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment
    Guanglin Qiu, Xuqi Li, Xiangming Che, Chao Wei, Shicai He, Jing Lu, Zongliang Jia, Ke Pang, Lin Fan
    FEBS Letters.2015; 589(16): 2034.     CrossRef
  • Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse
    Won Kyung Kang, Jin Kwon Lee, Seong Taek Oh, Sung Hak Lee, Chan Kwon Jung
    BMC Gastroenterology.2015;[Epub]     CrossRef
  • Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma
    Keiji Kikuchi, Akira Noguchi, Rika Kasajima, Yohei Miyagi, Daisuke Hoshino, Naohiko Koshikawa, Akira Kubota, Tomoyuki Yokose, Yasuo Takano
    Tumor Biology.2015; 36(10): 7865.     CrossRef
  • Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma
    Murat Kara, Onder Yumrutas, Onder Ozcan, Ozgur Ilhan Celik, Esra Bozgeyik, Ibrahim Bozgeyik, Sener Tasdemir
    Gene.2015; 567(1): 81.     CrossRef
  • Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype
    Yul Ri Chung, Hyojin Kim, Soo Young Park, In Ae Park, Ja June Jang, Ji-Young Choe, Yoon Yang Jung, Seock-Ah Im, Hyeong-Gon Moon, Kyung-Hun Lee, Koung Jin Suh, Tae-Yong Kim, Dong-Young Noh, Wonshik Han, Han Suk Ryu
    Human Pathology.2015; 46(7): 1027.     CrossRef
  • Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma
    Hyeyoon Chang, Woon Yong Jung, Youngran Kang, Hyunjoo Lee, Aeree Kim, Baek-hui Kim
    Annals of Diagnostic Pathology.2015; 19(5): 330.     CrossRef
  • miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression
    KUN DUAN, YONG-CHAO GE, XUE-PEI ZHANG, SHU-YI WU, JIN-SHUN FENG, SHI-LIN CHEN, LI ZHANG, ZHI-HAO YUAN, CHAO-HONG FU
    Oncology Letters.2015; 10(5): 3223.     CrossRef
  • Immunohistochemical Characterization of Large Intestinal Adenocarcinoma in the Rhesus Macaque (Macaca mulatta)
    C. E. Harbison, F. Taheri, H. Knight, A. D. Miller
    Veterinary Pathology.2015; 52(4): 732.     CrossRef
  • Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer
    Yu-Wen Cao, Wen-Qin Li, Guo-Xing Wan, Yi-Xiao Li, Xiao-Ming Du, Yu-Cong Li, Feng Li
    Journal of Experimental & Clinical Cancer Research.2014;[Epub]     CrossRef
  • Fentanyl Increases Colorectal Carcinoma Cell Apoptosis by Inhibition of NF-κB in a Sirt1-dependent Manner
    Xiu-Lai Zhang, Min-Li Chen, Sheng-Li Zhou
    Asian Pacific Journal of Cancer Prevention.2014; 15(22): 10015.     CrossRef
  • Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients
    J Zhan, M Niu, P Wang, X Zhu, S Li, J Song, H He, Y Wang, L Xue, W Fang, H Zhang
    British Journal of Cancer.2014; 111(5): 883.     CrossRef
  • Prognostic Factors for Metastatic Colorectal Cancer after First-line Chemotherapy with FOLFOX-4 or FOLFIRI Regimen
    Jae Hyun Kim, Pyoung Rak Choi, Seun Ja Park, Moo In Park, Won Moon, Sung Eun Kim, Gyu Won Lee
    The Korean Journal of Gastroenterology.2014; 63(4): 209.     CrossRef
  • Down-Regulation of mir-221 and mir-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1
    Xiao Yang, Yingmei Yang, Rong Gan, Lingxu Zhao, Wei Li, Huaibin Zhou, Xiaojuan Wang, Jianxin Lu, Qing H. Meng, George Calin
    PLoS ONE.2014; 9(6): e98833.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine